Associations of Disease-Modifying Therapies With COVID-19 Severity in Multiple Sclerosis. - Simpson-Yap S; De Brouwer E; Kalincik T; Rijke N; Hillert JA; Walton C; Edan G; Moreau Y; Spelman T; Geys L; Parciak T; Gautrais C; et al. (Neurology, 2021)